Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks

4. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Renaissance Technologies’ Q2 2023 Investment: $447 million

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology firm developing treatments for cystic fibrosis. The shares are rated Buy on average and analysts have set an average share price target of $388.67.

For their second quarter of 2023 investments, 54 out of the 910 hedge funds polled by Insider Monkey had bought the firm’s shareholders. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s biggest hedge fund shareholder is Jim Simons’ Renaissance Technologies as it owns $447 million worth of shares.

Follow Vertex Pharmaceuticals Inc / Ma (NASDAQ:VRTX)